Pepti · Catalog · Adipotide (FTTP)

Fat-targeted proapoptotic peptide · research-use

Adipotide (FTTP) OEM supply.

Bulk and private-label supply of the fat-targeted proapoptotic peptidomimetic, HPLC/MS-characterized and lot-documented for research and formulation programs.

Adipotide (FTTP) lyophilized vial
AdipotideHPLC ≥ 99%MS confirmed2mg

Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.

CompoundAdipotide (FTTP)
CAS number859216-15-2
Molecular formulaC111H206N36O28S2
Molecular weight2557.2 g/mol (free base)
SequenceCKGGRAKDC-GG-D(KLAKLAK)2
FormLyophilized powder, glass vial
Purity target≥ 99% by HPLC
Vial formats2mg / 5mg / 10mg
DocumentationBatch-linked COA + HPLC chromatogram + MS identity record for every production lot
Distribution scopeResearch use, worldwide
StorageLyophilized powder is typically stored at -20°C, protected from light and moisture; long-term stock is best kept frozen. After reconstitution, material is held at 2-8°C and used within a short working window. Exact stability and handling conditions are stated on each lot's COA.

MOQ & lead time

TierQuantityLead time
OEM lot50 kits (500 vials)3–7 days
Production lot500–1,000 vials10–14 days
OEM repeat1,000+ vials14–18 days, scheduled

Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.

Overview

About Adipotide (FTTP).

Adipotide (FTTP, "fat-targeted proapoptotic peptide"), also cataloged as prohibitin-targeting peptide 1, is a synthetic chimeric peptidomimetic fusing a cyclic CKGGRAKDC homing motif to a D-amino-acid D(KLAKLAK)2 proapoptotic domain. In published rodent and nonclinical primate literature the homing motif binds prohibitin and annexin A2 displayed on the vasculature supplying white adipose tissue, a mechanism studied in adipose blood-supply and apoptosis models.

Documentation

Batch documentation support for Adipotide (FTTP) lots.

batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.

HPLC purity

Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.

MS identity

Mass spectrometry identity confirmation against the Adipotide (FTTP) reference profile.

Lot traceability

Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.

FAQ

Adipotide (FTTP) — frequently asked by B2B buyers.

What documentation ships with each Adipotide (FTTP) lot?

Every lot is supplied with a Certificate of Analysis reporting identity and purity by RP-HPLC and mass spectrometry (ESI-MS or MALDI-TOF). Supporting data such as water content, acetate/counter-ion content, and endotoxin (only if specifically ordered and tested) can be provided on request.

What vial sizes and minimum order quantity are available?

Adipotide is stocked as lyophilized powder in 2mg, 5mg, and 10mg vials, with a standard MOQ of 50 kits (500 vials). Custom fill weights and larger bulk quantities are quoted on RFQ.

Can Pepti private-label or white-label Adipotide?

Yes. As an OEM/private-label manufacturer we support custom vial fills, labeling, kitting, and lot documentation for research-supply brands. Artwork, specifications, and counter-ion form are confirmed before production.

What purity is offered and how is the salt form reported?

Standard supply is typically ≥99% by HPLC. The reported free-base molecular weight is ~2557 g/mol (C111H206N36O28S2); material is generally provided as an acetate salt, and net peptide content is stated on the COA so buyers can account for counter-ion mass.

Is Adipotide sold for therapeutic use?

No. All material is supplied strictly for laboratory research and manufacturing use, not for consumer or veterinary consumption or any applied use. Buyers are responsible for regulatory compliance in their jurisdiction.

WhatsApp us